Liebscher, S.C.; Kilgore, L.J.; Winblad, O.; Gloyeske, N.; Larson, K.; Balanoff, C.; Nye, L.; O’Dea, A.; Sharma, P.; Kimler, B.;
et al. Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy. Healthcare 2023, 11, 417.
https://doi.org/10.3390/healthcare11030417
AMA Style
Liebscher SC, Kilgore LJ, Winblad O, Gloyeske N, Larson K, Balanoff C, Nye L, O’Dea A, Sharma P, Kimler B,
et al. Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy. Healthcare. 2023; 11(3):417.
https://doi.org/10.3390/healthcare11030417
Chicago/Turabian Style
Liebscher, Sean C., Lyndsey J. Kilgore, Onalisa Winblad, Nika Gloyeske, Kelsey Larson, Christa Balanoff, Lauren Nye, Anne O’Dea, Priyanka Sharma, Bruce Kimler,
and et al. 2023. "Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy" Healthcare 11, no. 3: 417.
https://doi.org/10.3390/healthcare11030417
APA Style
Liebscher, S. C., Kilgore, L. J., Winblad, O., Gloyeske, N., Larson, K., Balanoff, C., Nye, L., O’Dea, A., Sharma, P., Kimler, B., Khan, Q., & Wagner, J.
(2023). Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy. Healthcare, 11(3), 417.
https://doi.org/10.3390/healthcare11030417
